NPS Pharmaceuticals (NPSP)

7.93 -0.17 -2.10% May 30, 8:00PM Go Pro

Watch this stock

NPS Pharmaceuticals Return on Invested Capital: -22.98%

View NPSP Return on Invested Capital with YCharts Pro.

Access these YCharts Pro features:

Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience

and much more...

NPSP Return on Invested Capital Rankings

Overall	10th percentile	3742 of 4163
Sector	37th percentile	298 of 480 in Healthcare
Industry	61st percentile	59 of 152 in Biotechnology

NPSP Return on Invested Capital Range, Past 5 Years

Minimum	-55.81%	Jun 2007
Maximum	21.88%	Jun 2008
Average	-20.15%

About Return on Invested Capital (ROIC)

ROIC is an acronym for "Return on Invested Capital", and it is a concept that doesn't have a fixed definition. In YCharts, it is the net income that a company earned as a percentage of all of the capital given to a company by shareholders and debt holders. It is a ratio that tries to answer the question: "If I gave $1 to this company, how much money could the company earn by investing that $1?" A ROIC of 5% means that the company can return $0.05 per dollar invested.

ROIC is often considered a more reasonable estimate of managerial performance than Return on Equity (ROE) because it takes into account investments by debt holders, which should be invested to increase net income.

It is also more reasonable than Return on Assets (ROA) because it only assumes that capital which was "invested" into the company can be used to earn income.
Learn More

You may also be interested in these NPSP related companies

Options

NPSP News

NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference
May 29, 4:10PM Business Wire

[video] NPS Pharma CEO: Market Recognizing Pipeline Potential
May 28, 6:30AM

$NPSP Wonder if this spike has anything to do with CHMP decision?
about 7 days ago by Random_Walk

$NPSP
about 7 days ago by Random_Walk

RT @TheEquitiesRoom: EBR: Watchlist/worksheet/4 Trading Ideas: $DECK $CRR $NPSP $LOW $V http://stks.co/3wzM < thanks for sharing
about 8 days ago by 1nvestor

NPS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May 21, 4:10PM

$NPSP Close at highs, nice volume too. Can't figure out why this isn't getting more attention.
about 9 days ago by Random_Walk

U.S. Stock Options With Biggest Changes in Implied Volatility
May 21, 3:00PM

Digestive Disease Week Presentations Support Therapeutic Potential for Gattex (teduglutide) as Novel Treatment for Adult Short Bowel Syndrome
May 21, 8:00AM Business Wire

$NPSP Inside day on decent volume. Higher we go.
about 12 days ago by Random_Walk

$NPSP Nice rebound today after yesterday's selloff. Good volume for a change.
about 13 days ago by Random_Walk

[video] Stocks Under $10: Healthcare Name on Sale
May 17, 7:30AM

$NPSP http://stks.co/3pss Golden Cross, 50MA cross above the 200MA, breakingout the $7.39 resistance, positive momentum
about 16 days ago by gantosj

$NPSP $AKRX Strong today in an ugly tape.
about 16 days ago by Random_Walk

On The Fly: Analyst Initiation Summary
May 07, 10:32AM

Canaccord Genuity Starts NPS Pharmaceuticals Inc. (NPSP) at Buy
May 07, 9:04AM Street Insider

ThinkEquity, Canacord, S&P, Needham all have retiterated buy ratings on $NPSP in last week. Very undervalued considering potential here.
about 24 days ago by Random_Walk

NPS Pharmaceuticals coverage assumed with a Buy at Canaccord
May 07, 6:57AM

$NPSP 200 Day SMA Cross - Price crossed above 200 day SMA (6.8493). Confirmed by volume.
about 27 days ago by TradeIdeasQuant

$NPSP 200 Day SMA Cross - Price crossed below 200 day SMA (6.8493). Confirmed by volume.
about 27 days ago by TradeIdeasQuant

Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Awaiting Date for Gattex FDA AdCom Meeting
May 04, 9:25AM Street Insider

NPS Pharmaceuticals, Inc. (NPSP) Misses Q1 EPS by 1c
May 03, 5:11PM Street Insider

$NPSP filed latest Quarterly Report http://stks.co/3f9y
about 27 days ago by MarketBrief

NPS Pharmaceuticals Earnings Call scheduled for 5:00 pm ET today
May 03, 5:00PM

Listen to $NPSP Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3f5z
about 27 days ago by earningscast

NPS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
May 03, 4:37PM

NPS Pharmaceuticals Reports First Quarter 2012 Financial Results
May 03, 4:30PM Business Wire

NPS Pharmaceuticals Reports Four Additional Patients Achieve Independence from Parenteral Support in STEPS 2 Study of Gattex® in Adult Short Bowel Syndrome
May 03, 8:04AM Benzinga

$NPSP Decent volume today. Keep it goin'!
about 30 days ago by Random_Walk

$NPSP No love for $NPSP? Nice breakout today, albeit on low volume. Long from 7.10. Holding. http://chart.ly/2f5qte9
about 33 days ago by Random_Walk

$NPSP http://stks.co/3YQG breaking out the channel testing the upper line and bouncing back, looks good with positive momentum
about 34 days ago by gantosj

NPS Pharmaceuticals to Report First Quarter 2012 Financial Results
Apr 27, 8:15AM Business Wire

$NPSP Flirting with breakout. Need someone to pump up the volume!!
about 35 days ago by Random_Walk

NPS Pharmaceuticals Among 100 Best Places to Work in New Jersey
Apr 26, 8:44AM Business Wire

IV30(TM) GAINER $AH +62.75% $AMRN +21.58% $NFLX +12.61% $ONXX +11.05% $NPSP +10.4% $SODA +9.72% $INFN +9.02% $SPPI +7.8% $EQIX +7.31%
about 36 days ago by livevol_pro

HIGH $PUT VOLU $BBG 13580% $KFN 1653% $BWA 811% $BMC 793% $NPSP 757% $GPS 726% $THLD 657% $ONXX 622% $FNSR 504% $GRA 463%
about 36 days ago by livevol_pro

$NPSP Volume perking up. Upcoming catalyst. Approaching breakout. Keep an eye on $NPSP.
about 36 days ago by Random_Walk

NPS Pharmaceuticals: The Next Orphan-Drug Powerhouse?
Apr 24, 8:57AM

Annual Report with 10K for NPS Pharmaceuticals
Apr 19, 8:00PM

@RmanAudio Agreed. I've had my eye on $NPSP for awhile.
about 42 days ago by Random_Walk

$NPSP http://stks.co/3Ogl Trading in a horizontal channel, Bollinger band in a Volatility Squeeze, near term catalyst
about 43 days ago by gantosj

$NPSP http://stks.co/3LuR consolidating with a move over 7 targetting 7.83, under 6.38 targets 5.50
about 46 days ago by harmongreg

$NPSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3KmH
about 48 days ago by MarketBrief

NPS Pharmaceuticals to Present at Needham Healthcare Conference
Mar 27, 4:10PM Business Wire

NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference
Mar 07, 4:10PM Business Wire

Looking For Solid Science in Biotech
Mar 05, 3:52PM

NPS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
Feb 29, 4:20PM

NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Feb 29, 8:10AM Business Wire

NPS Pharmaceuticals Observes Rare Disease Day 2012
Feb 27, 8:00AM Business Wire

DIARY-U.S. MEETINGS/WEEK AHEAD
Feb 24, 6:37AM

DIARY-U.S. MEETINGS/WEEK AHEAD
Feb 23, 7:52AM

NPS PHARMACEUTICALS INC Financials
Feb 22, 1:04PM

NPS Pharmaceuticals to Present at Upcoming Conferences
Feb 21, 4:10PM Business Wire

Canaccord Genuity Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Underappreciated Cumulative Value for GATTEX, NATPARA, and Sensipar Royalty
Feb 16, 10:00AM Street Insider

New Star Analyst Rankings for NPS Pharmaceuticals, Inc.
Feb 16, 9:30AM

Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Gattex PDUFA Date Announced, but FDA AdCom Timing Still Unknown
Feb 16, 8:51AM Street Insider

NPS Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
Feb 15, 5:00PM

NPS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
Feb 15, 4:37PM

NPS Pharmaceuticals, Inc. (NPSP) Posts Wider than Expected Q4 Loss
Feb 15, 4:34PM Street Insider

NPS Pharmaceuticals Reports 2011 Year-End Financial Results and 2012 Cash Burn Guidance
Feb 15, 4:30PM Business Wire

Q4 2011 NPS Pharmaceuticals Inc Earnings Release - After Market Close
Feb 15, 7:07AM

NPS Pharmaceuticals to Report 2011 Financial Results
Feb 08, 4:10PM Business Wire

NPS Pharmaceuticals to Present at Upcoming Conferences
Feb 06, 4:10PM Business Wire

NPS Pharma's (NPSP) NDA for GATTEX Accepted by FDA
Jan 31, 8:07AM Street Insider

NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX
Jan 31, 8:04AM Benzinga

NPS Pharma (NPSP) announces FDA acceptance of NDA for Gattex(R) in adult SBS
Jan 31, 8:04AM Street Insider

InPlay: NPS Pharm announces FDA acceptance of New Drug Application for GATTEX for the Treatment of adult short bowel syndrome
Jan 31, 8:02AM

NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX® (teduglutide) for the Treatment of Adult Short Bowel Syndrome (SBS)
Jan 31, 8:00AM Business Wire

Notable Call Options Activity in NPS Pharmaceuticals
Jan 10, 10:15AM Benzinga

NPS Pharm. Gets "Buy" Recommendation, Heads for Conference
Jan 06, 3:37PM

Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Shares Undervalued
Jan 06, 10:29AM Street Insider

NPS Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 05, 4:10PM Business Wire

7 Biotechs Under $8 Poised For A January Surge
Dec 15, 4:59PM

NPS Pharmaceuticals (NPSP) Completes GATTEX NDA Submission to FDA
Dec 01, 8:24AM Street Insider

Recent Quotes

Symbol	Price	Chg	Chg %	Market Cap
NPSP	7.93	-0.17	-2.10%	697.49M
NPM	15.24	+0.03	+0.20%
NPK	66.00	-0.43	-0.65%	457.04M
NNBR	7.68	-0.39	-4.83%	136.79M
NNA	2.585	-0.01	-0.19%	104.95M
NMT	15.12	-0.11	-0.71%
NMRX	8.92	-0.06	-0.67%	136.14M
NMR	3.27	-0.05	-1.51%	12.16B
NMM	13.98	-0.37	-2.58%	672.87M
NMD	12.32	+0.01	+0.08%

Create Watchlist from Stock Quotes